miRNA: The nemesis of gastric cancer (Review)

Oncology Letters

Volumn 6, Issue 3, 2013, Pages 631-641

  Xu, Xiaohui ^a   Yang, Xiaodong ^a   Xing, Chungen ^a   Zhang, Shuyu ^b   Cao, Jianping ^b  

^a THE SECOND AFFILIATED HOSPITAL OF SOOCHOW UNIVERSITY   (China)

^b MEDICAL COLLEGE OF SOOCHOW UNIVERSITY   (China)

Author keywords

Biomarker; Exosome; Gastric cancer; miRNA; Plasma; Serum

Indexed keywords

CASPASE 7; CCAAT ENHANCER BINDING PROTEIN ALPHA; CONNECTIVE TISSUE GROWTH FACTOR; CYCLIN DEPENDENT KINASE 4; CYCLIN DEPENDENT KINASE 6; CYCLIN E; K RAS PROTEIN; MICRORNA; MICRORNA 145; MICRORNA 21; MICRORNA 223; MICRORNA 34A; MICRORNA 9; MITOGEN ACTIVATED PROTEIN KINASE 1; MYC PROTEIN; P21 ACTIVATED KINASE 2; PROTEIN BCL 2; PROTEIN CDC42; PROTEIN P53; RETINOBLASTOMA PROTEIN; RIBONUCLEASE III; RNA INDUCED SILENCING COMPLEX; RNA POLYMERASE II; SCATTER FACTOR RECEPTOR; SMAD4 PROTEIN; SMALL INTERFERING RNA; THROMBOSPONDIN 1; TRANSCRIPTION FACTOR E2F1; UNINDEXED DRUG; UVOMORULIN;

APOPTOSIS; ARTICLE; CANCER PROGNOSIS; CANCER STAGING; CARCINOGENICITY; CELL CYCLE ARREST; CELL GROWTH; CELL INVASION; CELL MIGRATION; CELL PROLIFERATION; DISEASE COURSE; DOWN REGULATION; GENE EXPRESSION; HUMAN; METASTASIS; MICROARRAY ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION; RECURRENCE FREE SURVIVAL; RNA SYNTHESIS; SIGNAL TRANSDUCTION; STOMACH CANCER; STOMACH CARCINOGENESIS; TUMOR VOLUME; UPREGULATION;

EID: 84880432278     PISSN: 17921074     EISSN: 17921082     Source Type: Journal    
DOI: 10.3892/ol.2013.1428     Document Type: Article

References (121)

1. Jemal A, Bray F, Center MM, Ferlay J, Ward E and Forman D: Global cancer statistics. CA Cancer J Clin 61: 69-90, 2011.
2. Schoof CR, Botelho EL, Izzotti A and Vasques Ldos R: MicroRNAs in cancer treatment and prognosis. Am J Cancer Res 2: 414-433, 2012.
3. Yu BQ, Su LP, Li JF, Cai Q, Yan M, Chen XH, et al: microRNA expression signature of gastric cancer cells relative to normal gastric mucosa. Mol Med Rep 6: 821-826, 2012.
4. Ueda T, Volinia S, Okumura H, Shimizu M, Taccioli C, Rossi S, et al: Relation between microRNA expression and progression and prognosis of gastric cancer: a microRNA expression analysis. Lancet Oncol 11: 136-146, 2010.
5. Tsujiura M, Ichikawa D, Komatsu S, Shiozaki A, Takeshita H, Kosuga T, et al: Circulating microRNAs in plasma of patients with gastric cancers. Br J Cancer 102: 1174-1179, 2010.
6. Lee RC, Feinbaum RL and Ambros V: The C. elegans heterochronic gene lin-4 encodes small RNAs with antisense complementarity to lin-14. Cell 75: 843-854, 1993.
7. Wightman B, Ha I and Ruvkun G: Posttranscriptional regulation of the heterochronic gene lin-14 by lin-4 mediates temporal pattern formation in C. elegans. Cell 75: 855-862, 1993.
8. Reinhart BJ, Slack FJ, Basson M, Pasquinelli AE, Bettinger JC, Rougvie AE, et al: The 21-nucleotide let-7 RNA regulates developmental timing in Caenorhabditis elegans. Nature 403: 901-906, 2000.
9. Hutvagner G, McLachlan J, Pasquinelli AE, et al: A cellular function for the RNA-interference enzyme Dicer in the maturation of the let-7 small temporal RNA. Science 293: 834-838, 2001.
10. Han J, Lee Y, Yeom KH, Nam JW, Heo I, Rhee JK, et al: Molecular basis for the recognition of primary microRNAs by the Drosha-DGCR8 complex. Cell 125: 887-901, 2006.
11. Klase Z, Houzet L and Jeang KT: Replication competent HIV-1 viruses that express intragenomic microRNA reveal discrete RNA-interference mechanisms that affect viral replication. Cell Biosci 1: 38, 2011.
12. Bernstein E, Caudy AA, Hammond SM and Hannon GJ: Role for a bidentate ribonuclease in the initiation step of RNA interference. Nature 409: 363-366, 2001.
13. Han J, Lee Y, Yeom KH, Kim YK, Jin H and Kim VN: The Drosha-DGCR8 complex in primary microRNA processing. Genes Dev 18: 3016-3027, 2004.
14. Lee Y, Kim M, Han J, Yeom KH, Lee S, Baek SH and Kim VN: MicroRNA genes are transcribed by RNA polymerase II. EMBO J 23: 4051-4060, 2004.
15. Cai X, Hagedorn CH and Cullen BR: Human microRNAs are processed from capped, polyadenylated transcripts that can also function as mRNAs. RNA 10: 1957-1966, 2004.
16. Kim YK and Kim VN: Processing of intronic microRNAs. EMBO J 26: 775-783, 2007.
17. Kim VN: MicroRNA biogenesis: coordinated cropping and dicing. Nat Rev Mol Cell Biol 6: 376-385, 2005.
18. Kusenda B, Mraz M, Mayer J and Pospisilova S: MicroRNA biogenesis, functionality and cancer relevance. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub 150: 205-215, 2006.
19. Place RF, Li LC, Pookot D, Noonan EJ and Dahiya R: MicroRNA-373 induces expression of genes with complementary promoter sequences. Proc Natl Acad Sci USA 105: 1608-1613, 2008.
20. Vasudevan S, Tong Y and Steitz JA: Switching from repression to activation: microRNAs can up-regulate translation. Science 318: 1931-1934, 2007.
21. Mattaj IW, Tollervey D and Séraphin B: Small nuclear RNAs in messenger RNA and ribosomal RNA processing. FASEB J 7: 47-53, 1993.
22. Bachellerie JP, Cavaillé J and Hüttenhofer A: The expanding snoRNA world. Biochimie 84: 775-790, 2002.
23. Ambros V, Lee RC, Lavanway A, Williams PT and Jewell D: MicroRNAs and other tiny endogenous RNAs in C. elegans. Curr Biol 13: 807-818, 2003.
24. Du T and Zamore PD: microPrimer: the biogenesis and function of microRNA. Development 132: 4645-4652, 2005.
25. Lim LP, Glasner ME, Yekta S, Burge CB and Bartel DP: Vertebrate microRNA genes. Science 299: 1540, 2003.
26. Chan JA, Krichevsky AM and Kosik KS: MicroRNA-21 is an antiapoptotic factor in human glioblastoma cells. Cancer Res 65: 6029-6033, 2005.
27. Cheng AM, Byrom MW, Shelton J and Ford LP: Antisense inhibition of human miRNAs and indications for an involvement of miRNA in cell growth and apoptosis. Nucleic Acids Res 33: 1290-1297, 2005.
28. Santarpia L, Nicoloso M and Calin GA: MicroRNAs: a complex regulatory network drives the acquisition of malignant cell phenotype. Endocr Relat Cancer 17: F51-F75, 2010.
29. Mattie MD, Benz CC, Bowers J, et al: Optimized high-throughput microRNA expression profiling provides novel biomarker assessment of clinical prostate and breast cancer biopsies. Mol Cancer 5: 24, 2006.
30. Volinia S, Calin GA, Liu CG, Ambs S, Cimmino A, Petrocca F, et al: A microRNA expression signature of human solid tumors defines cancer gene targets. Proc Natl Acad Sci USA 103: 2257-2261, 2006.
31. Grady WM, Parkin RK, Mitchell PS, Lee JH, Kim YH, Tsuchiya KD, et al: Epigenetic silencing of the intronic microRNA hsa-miR-342 and its host gene EVL in colorectal cancer. Oncogene 27: 3880-3888, 2008.
32. Lanza G, Ferracin M, Gafà R, Veronese A, Spizzo R, Pichiorri F, mRNA/microRNA gene expression profile in microsatellite unstable colorectal cancer. Mol Cancer 6: 54, 2007.
33. Gaur A, Jewell DA, Liang Y, Ridzon D, Moore JH, Chen C, et al: Characterization of microRNA expression levels and their biological correlates in human cancer cell lines. Cancer Res 67: 2456-2468, 2007.
34. Saito Y, Suzuki H and Hibi T: The role of microRNAs in gastrointestinal cancers. J Gastroenterol 44 (Suppl 19): 18-22, 2009.
35. Ma L, Young J, Prabhala H, Pan E, Mestdagh P, Muth D, et al: miR-9, a MYC/MYCN-activated microRNA, regulates E-cadherin and cancer metastasis. Nat Cell Biol 12: 247-256, 2010.
36. Noonan EJ, Place RF, Basak S, Pookot D and Li LC: miR-449a causes Rb-dependent cell cycle arrest and senescence in prostate cancer cells. Oncotarget 1: 349-358, 2010.
37. Pulikkan JA, Dengler V, Peramangalam PS, Peer Zada AA, Müller-Tidow C, Bohlander SK, et al: Cell-cycle regulator E2F1 and microRNA-223 comprise an autoregulatory negative feedback loop in acute myeloid leukemia. Blood 115: 1768-1778, 2010.
38. Hermeking H: The miR-34 family in cancer and apoptosis. Cell Death Differ 17: 193-199, 2010.
39. Vogt M, Munding J, Grüner M, Liffers ST, Verdoodt B, Hauk J, et al: Frequent concomitant inactivation of miR-34a and miR-34b/c by CpG methylation in colorectal, pancreatic, mammary, ovarian, urothelial, and renal cell carcinomas and soft tissue sarcomas. Virchows Arch 458: 313-322, 2011.
40. Allgayer H: Pdcd4, a colon cancer prognostic that is regulated by a microRNA. Crit Rev Oncol Hematol 73: 185-191, 2010.
41. Lu Z, Liu M, Stribinskis V, Klinge CM, Ramos KS, Colburn NH and Li Y: MicroRNA-21 promotes cell transformation by targeting the programmed cell death 4 gene. Oncogene 27: 4373-4379, 2008.
42. Dews M, Homayouni A, Yu D, Murphy D, Sevignani C, Wentzel E, et al: Augmentation of tumor angiogenesis by a Myc-activated microRNA cluster. Nat Genet 38: 1060-1065, 2006.
43. Spizzo R, Nicoloso MS, Lupini L, Lu Y, Fogarty J, Rossi S, et al: miR-145 participates with TP53 in a death-promoting regulatory loop and targets estrogen receptor-alpha in human breast cancer cells. Cell Death Differ 17: 246-254, 2010.
44. Hao J, Zhang S, Zhou Y, Hu X and Shao C: MicroRNA 483-3p suppresses the expression of DPC4/Smad4 in pancreatic cancer. FEBS Lett 585: 207-213, 2011.
45. Hao J, Zhang S, Zhou Y, Liu C, Hu X and Shao C: MicroRNA 421 suppresses DPC4/Smad4 in pancreatic cancer. Biochem Biophys Res Commun 406: 552-557, 2011.
46. Zhang Y, Takahashi S, Tasaka A, Yoshima T, Ochi H and Chayama K: Involvement of microRNA-224 in cell proliferation, migration, invasion and anti-apoptosis in hepatocellular carcinoma. J Gastroenterol Hepatol 28: 565-575, 2013.
47. Hudson RS, Yi M, Esposito D, Glynn SA, Starks AM, Yang Y, et al: MicroRNA-106b-25 cluster expression is associated with early disease recurrence and targets caspase-7 and focal adhesion in human prostate cancer. Oncogene Sep 17, 2012 (Epub ahead of print).
48. Kasinski AL and Slack FJ: miRNA-34 prevents cancer initiation and progression in a therapeutically resistant K-ras and p53-induced mouse model of lung adenocarcinoma. Cancer Res 72: 5576-5587, 2012.
49. Panarelli NC and Yantiss RK: MicroRNA Expression in Selected Carcinomas of the Gastrointestinal Tract. Patholog Res Int 2011: 124608, 2011.
50. Tokumaru Y, Yamashita K, Osada M, et al: Inverse correlation between cyclin A1 hypermethylation and p53 mutation in head and neck cancer identified by reversal of epigenetic silencing. Cancer Res 64: 5982-5987, 2004.
51. Wittmann J and Jäck HM: Serum microRNAs as powerful cancer biomarkers. Biochim Biophys Acta 1806: 200-207, 2010.
52. Krutovskikh VA and Herceg Z: Oncogenic microRNAs (OncomiRs) as a new class of cancer biomarkers. Bioessays 32: 894-904, 2010.
53. Brase JC, Wuttig D, Kuner R and Sültmann H: Serum microRNAs as non-invasive biomarkers for cancer. Mol Cancer 9: 306, 2010.
54. Lawrie CH, Gal S, Dunlop HM, Pushkaran B, Liggins AP, Pulford K, et al: Detection of elevated levels of tumour-associated microRNAs in serum of patients with diffuse large B-cell lymphoma. Br J Haematol 141: 672-675, 2008.
55. Wang J, Chen J, Chang P, LeBlanc A, Li D, Abbruzzesse JL, et al: MicroRNAs in plasma of pancreatic ductal adenocarcinoma patients as novel blood-based biomarkers of disease. Cancer Prev Res (Phila) 2: 807-813, 2009.
56. Mitchell PS, Parkin RK, Kroh EM, Fritz BR, Wyman SK, Pogosova-Agadjanyan EL, et al: Circulating microRNAs as stable blood-based markers for cancer detection. Proc Natl Acad Sci USA 105: 10513-10518, 2008.
57. Ng EK, Chong WW, Jin H, Lam EK, Shin VY, Yu J, et al: Differential expression of microRNAs in plasma of patients with colorectal cancer: a potential marker for colorectal cancer screening. Gut 58: 1375-1381, 2009.
58. Cheng H, Zhang L, Cogdell DE, Zheng H, Schetter AJ, Nykter M, et al: Circulating plasma MiR-141 is a novel biomarker for metastatic colon cancer and predicts poor prognosis. PLoS One 6: e17745, 2011.
59. Huang Z, Huang D, Ni S, Peng Z, Sheng W and Du X: Plasma microRNAs are promising novel biomarkers for early detection of colorectal cancer. Int J Cancer 127: 118-126, 2010.
60. Wang LG and Gu J: Serum microRNA-29a is a promising novel marker for early detection of colorectal liver metastasis. Cancer Epidemiol 36: e61-e67, 2012.
61. Luo X, Burwinkel B, Tao S and Brenner H: MicroRNA signatures: novel biomarker for colorectal cancer? Cancer Epidemiol Biomarkers Prev 20: 1272-1286, 2011.
62. Pu XX, Huang GL, Guo HQ, Guo CC, Li H, Ye S, et al: Circulating miR-221 directly amplified from plasma is a potential diagnostic and prognostic marker of colorectal cancer and is correlated with p53 expression. J Gastroenterol Hepatol 25: 1674-1680, 2010.
63. Hennessey PT, Sanford T, Choudhary A, Mydlarz WW, Brown D, Adai AT, et al: Serum microRNA biomarkers for detection of non-small cell lung cancer. PLoS One 7: e32307, 2012.
64. Yuxia M, Zhennan T and Wei Z: Circulating miR-125b is a novel biomarker for screening non-small-cell lung cancer and predicts poor prognosis. J Cancer Res Clin Oncol 138: 2045-2050, 2012.
65. Kosaka N, Iguchi H and Ochiya T: Circulating microRNA in body fluid: a new potential biomarker for cancer diagnosis and prognosis. Cancer Sci 101: 2087-2092, 2010.
66. Bou Kheir T, Futoma-Kazmierczak E, Jacobsen A, Krogh A, Bardram L, Hother C, et al: miR-449 inhibits cell proliferation and is down-regulated in gastric cancer. Mol Cancer 10: 29, 2011.
67. Zhang Z, Li Z, Gao C, Chen P, Chen J, Liu W, et al: miR-21 plays a pivotal role in gastric cancer pathogenesis and progression. Lab Invest 88: 1358-1366, 2008.
68. Zhang BG, Li JF, Yu BQ, Zhu ZG, Liu BY and Yan M: microRNA-21 promotes tumor proliferation and invasion in gastric cancer by targeting PTEN. Oncol Rep 27: 1019-1026, 2012.
69. Luo H, Zhang H, Zhang Z, Zhang X, Ning B, Guo J, et al: Down-regulated miR-9 and miR-433 in human gastric carcinoma. J Exp Clin Cancer Res 28: 82, 2009.
70. Kim YK, Yu J, Han TS, Park SY, Namkoong B, Kim DH, et al: Functional links between clustered microRNAs: suppression of cell-cycle inhibitors by microRNA clusters in gastric cancer. Nucleic Acids Res 37: 1672-1681, 2009.
71. Tsukamoto Y, Nakada C, Noguchi T, Tanigawa M, Nguyen LT, Uchida T, et al: MicroRNA-375 is downregulated in gastric carcinomas and regulates cell survival by targeting PDK1 and 14-3-3zeta. Cancer Res 70: 2339-2349, 2010.
72. Ding L, Xu Y, Zhang W, Deng Y, Si M, Du Y, et al: MiR-375 frequently downregulated in gastric cancer inhibits cell proliferation by targeting JAK2. Cell Res 20: 784-793, 2010.
73. Xu Y, Deng Y, Yan X and Zhou T: Targeting miR-375 in gastric cancer. Expert Opin Ther Targets 15: 961-972, 2011.
74. Wan HY, Guo LM, Liu T, Liu M, Li X and Tang H: Regulation of the transcription factor NF-kappaB1 by microRNA-9 in human gastric adenocarcinoma. Mol Cancer 9: 16, 2010.
75. Du Y, Xu Y, Ding L, Yao H, Yu H, Zhou T and Si J: Down-regulation of miR-141 in gastric cancer and its involvement in cell growth. J Gastroenterol 44: 556-561, 2009.
76. Zhang Y, Fan KJ, Sun Q, Chen AZ, Shen WL, Zhao ZH, et al: Functional screening for miRNAs targeting Smad4 identified miR-199a as a negative regulator of TGF-β signalling pathway. Nucleic Acids Res 40: 9286-9297, 2012.
77. Zhang X, Nie Y, Du Y, Cao J, Shen B and Li Y: MicroRNA-181a promotes gastric cancer by negatively regulating tumor suppressor KLF6. Tumour Biol 33: 1589-1597, 2012.
78. Chen L, Yang Q, Kong WQ, Liu T, Liu M, Li X and Tang H: MicroRNA-181b targets cAMP responsive element binding protein 1 in gastric adenocarcinomas. IUBMB Life 64: 628-635, 2012.
79. Xia J, Wu Z, Yu C, He W, Zheng H, He Y, et al: miR-124 inhibits cell proliferation in gastric cancer through down-regulation of SPHK1. J Pathol 227: 470-480, 2012.
80. Li C, Nie H, Wang M, Su L, Li J, Yu B, et al: MicroRNA-409-3p regulates cell proliferation and apoptosis by targeting PHF10 in gastric cancer. Cancer Lett 320: 189-197, 2012.
81. Kong WQ, Bai R, Liu T, Cai CL, Liu M, Li X and Tang H: MicroRNA-182 targets cAMP-responsive element-binding protein 1 and suppresses cell growth in human gastric adenocarcinoma. FEBS J 279: 1252-1260, 2012.
82. Li J, Guo Y, Liang X, Sun M, Wang G, De W and Wu W: MicroRNA-223 functions as an oncogene in human gastric cancer by targeting FBXW7/hCdc4. J Cancer Res Clin Oncol 138: 763-774, 2012.
83. Zheng B, Liang L, Huang S, Zha R, Liu L, Jia D, et al: MicroRNA-409 suppresses tumour cell invasion and metastasis by directly targeting radixin in gastric cancers. Oncogene 31: 4509-4516, 2012.
84. Zhang Z, Liu S, Shi R and Zhao G: miR-27 promotes human gastric cancer cell metastasis by inducing epithelial-to-mesenchymal transition. Cancer Genet 204: 486-491, 2011.
85. Wang M, Li C, Nie H, Lv X, Qu Y, Yu B, et al: Down-regulated miR-625 suppresses invasion and metastasis of gastric cancer by targeting ILK. FEBS Lett 586: 2382-2388, 2012.
86. Li Z, Cao Y, Jie Z, Liu Y, Li Y, Li J, et al: miR-495 and miR-551a inhibit the migration and invasion of human gastric cancer cells by directly interacting with PRL-3. Cancer Lett 323: 41-47, 2012.
87. Liu Z, Zhu J, Cao H, Ren H and Fang X: miR-10b promotes cell invasion through RhoC-AKT signaling pathway by targeting HOXD10 in gastric cancer. Int J Oncol 40: 1553-1560, 2012.
88. Liao YL, Hu LY, Tsai KW, Wu CW, Chan WC, Li SC, et al: Transcriptional regulation of miR-196b by ETS2 in gastric cancer cells. Carcinogenesis 33: 760-769, 2012.
89. Gao P, Xing AY, Zhou GY, Zhang TG, Zhang JP, Gao C, et al: The molecular mechanism of microRNA-145 to suppress invasion-metastasis cascade in gastric cancer. Oncogene 32: 491-501, 2013.
90. Wang J, Zhang J, Wu J, Luo D, Su K, Shi W, et al: MicroRNA-610 inhibits the migration and invasion of gastric cancer cells by suppressing the expression of vasodilator-stimulated phosphoprotein. Eur J Cancer 48: 1904-1913, 2012.
91. Leja M, Wex T and Malfertheiner P: Markers for gastric cancer premalignant lesions: where do we go? Dig Dis 30: 268-276, 2012.
92. Calin GA and Croce CM: MicroRNA signatures in human cancers. Nat Rev Cancer 6: 857-866, 2006.
93. Chan SH, Wu CW, Li AF, Chi CW and Lin WC: miR-21 microRNA expression in human gastric carcinomas and its clinical association. Anticancer Res 28: 907-911, 2008.
94. Xu Y, Sun J, Xu J, Li Q, Guo Y and Zhang Q: miR-21 Is a Promising Novel Biomarker for Lymph Node Metastasis in Patients with Gastric Cancer. Gastroenterol Res Pract 2012: 640168, 2012.
95. Xiao B, Guo J, Miao Y, Jiang Z, Huan R, Zhang Y, et al: Detection of miR-106a in gastric carcinoma and its clinical significance. Clin Chim Acta 400: 97-102, 2009.
96. Chiang Y, Song Y, Wang Z, Chen Y, Yue Z, Xu H, et al: Aberrant expression of miR-203 and its clinical significance in gastric and colorectal cancers. J Gastrointest Surg 15: 63-70, 2011.
97. Takagi T, Iio A, Nakagawa Y, Naoe T, Tanigawa N and Akao Y: Decreased expression of microRNA-143 and-145 in human gastric cancers. Oncology 77: 12-21, 2009.
98. Su Y, Ni Z, Wang G, Cui J, Wei C, Wang J, et al: Aberrant expression of microRNAs in gastric cancer and biological significance of miR-574-3p. Int Immunopharmacol 13: 468-475, 2012.
99. Guo JX, Tao QS, Lou PR, Chen XC, Chen J and Yuan GB: miR-181b as a potential molecular target for anticancer therapy of gastric neoplasms. Asian Pac J Cancer Prev 13: 2263-2267, 2012.
100. Zhao X, Dou W, He L, Liang S, Tie J, Liu C, et al: MicroRNA-7 functions as an anti-metastatic microRNA in gastric cancer by targeting insulin-like growth factor-1 receptor. Oncogene 32: 1363-1372, 2013.
101. Jiang W, Chen X, Liao M, et al: Identification of links between small molecules and miRNAs in human cancers based on transcriptional responses. Sci Rep 2: 282, 2012.
102. Liu T, Tang H, Lang Y, Liu M and Li X: MicroRNA-27a functions as an oncogene in gastric adenocarcinoma by targeting prohibitin. Cancer Lett 273: 233-242, 2009.
103. Jiang Z, Guo J, Xiao B, Miao Y, Huang R, Li D and Zhang Y: Increased expression of miR-421 in human gastric carcinoma and its clinical association. J Gastroenterol 45: 17-23, 2010.
104. Link A, Kupcinskas J, Wex T, et al: Macro-role of microRNA in gastric cancer. Dig Dis 30: 255-267, 2012.
105. Tarasov V, Jung P, Verdoodt B, Lodygin D, Epanchintsev A, Menssen A, et al: Differential regulation of microRNAs by p53 revealed by massively parallel sequencing: miR-34a is a p53 target that induces apoptosis and G1-arrest. Cell Cycle 6: 1586-1593, 2007.
106. Ji Q, Hao X, Meng Y, Zhang M, Desano J, Fan D and Xu L: Restoration of tumor suppressor miR-34 inhibits human p53-mutant gastric cancer tumorspheres. BMC Cancer 8: 266, 2008.
107. Xia L, Zhang D, Du R, Pan Y, Zhao L, Sun S, et al: miR-15b and miR-16 modulate multidrug resistance by targeting BCL2 in human gastric cancer cells. Int J Cancer 123: 372-379, 2008.
108. Shen J, Wan R, Hu G, et al: miR-15b and miR-16 induce the apoptosis of rat activated pancreatic stellate cells by targeting Bcl-2 in vitro. Pancreatology 12: 91-99, 2012.
109. Wang J, Wang Q, Liu H, Hu B, Zhou W and Cheng Y: MicroRNA expression and its implication for the diagnosis and therapeutic strategies of gastric cancer. Cancer Lett 297: 137-143, 2010.
110. Lastraioli E, Romoli MR and Arcangeli A: Immunohistochemical biomarkers in gastric cancer research and management. Int J Surg Oncol 2012: 868645, 2012.
111. Grady WM and Tewari M: The next thing in prognostic molecular markers: microRNA signatures of cancer. Gut 59: 706-708, 2010.
112. Chen L, Jiang M, Yuan W and Tang H: Prognostic value of miR-93 overexpression in resectable gastric adenocarcinomas. Acta Gastroenterol Belg 75: 22-27, 2012.
113. Inoue T, Iinuma H, Ogawa E, Inaba T and Fukushima R: Clinicopathological and prognostic significance of microRNA-107 and its relationship to DICER1 mRNA expression in gastric cancer. Oncol Rep 27: 1759-1764, 2012.
114. Tsai KW, Liao YL, Wu CW, Hu LY, Li SC, Chan WC, et al: Aberrant expression of miR-196a in gastric cancers and correlation with recurrence. Genes Chromosomes Cancer 51: 394-401, 2012.
115. Hashiguchi Y, Nishida N, Mimori K, Sudo T, Tanaka F, Shibata K, et al: Down-regulation of miR-125a-3p in human gastric cancer and its clinicopathological significance. Int J Oncol 40: 1477-1482, 2012.
116. Konishi H, Ichikawa D, Komatsu S, Shiozaki A, Tsujiura M, Takeshita H, et al: Detection of gastric cancer-associated microRNAs on microRNA microarray comparing pre-and post-operative plasma. Br J Cancer 106: 740-747, 2012.
117. Wang M, Gu H, Wang S, Qian H, Zhu W, Zhang L, et al: Circulating miR-17-5p and miR-20a: molecular markers for gastric cancer. Mol Med Report 5: 1514-1520, 2012.
118. Song MY, Pan KF, Su HJ, Zhang L, Ma JL, Li JY, et al: Identification of serum microRNAs as novel non-invasive biomarkers for early detection of gastric cancer. PLoS One 7: e33608, 2012.
119. Liu H, Zhu L, Liu B, Yang L, Meng X, Zhang W, et al: Genome-wide microRNA profiles identify miR-378 as a serum biomarker for early detection of gastric cancer. Cancer Lett 316: 196-203, 2012.
120. Chim SS, Shing TK, Hung EC, Leung TY, Lau TK, Chiu RW and Lo YM: Detection and characterization of placental microRNAs in maternal plasma. Clin Chem 54: 482-490, 2008.
121. Ohshima K, Inoue K, Fujiwara A, Hatakeyama K, Kanto K, Watanabe Y, et al: Let-7 microRNA family is selectively secreted into the extracellular environment via exosomes in a metastatic gastric cancer cell line. PLoS One 5: e13247, 2010.